期刊文献+

实验性糖尿病肾病大鼠模型建立及优化 被引量:29

Optimal selection of rat models of experimental diabetic nephropathy
下载PDF
导出
摘要 目的比较几种不同因素组合对实验性糖尿病肾病大鼠模型建立中大鼠体质量、血糖及尿微量白蛋白的影响,确定建立糖尿病肾病大鼠模型的最佳方案。方法雄性SD大鼠30只,随机分为5组,每组6只。A组(正常对照组),B组(高糖高脂饲料),C组高糖高脂饲料+链脲佐菌素(Streptozotocin,STZ)组,D组(高糖高脂饲料+阿霉素+STZ组),E组(高糖高脂饲料+单肾切除+STZ组)。大鼠造模后每2周测体质量、进食量、饮水量、血糖及尿微量白蛋白。造模12周后,处死大鼠。结果E组大鼠明显多食、多饮、消瘦、血糖升高,尿微量白蛋白不仅与正常组比较有显著差异,并且与前几个模型组比较也都有显著性差异。肾/体质量比显著增大。结论以大鼠高糖高脂饲料4周后单肾切除,2周后小剂量腹腔注射链脲佐菌素的模型为最佳。 Objective To compare different combinations of several factors in establishing rat model ot experimental diabetic nephropathy and decide the preferred plan. Methods Thirty SD rats were randomly divided into 5 groups with six rats in every group. A was normal group; B was high-lipids and high-sucrose feeding group ; C was high-lipids and high-sucrose feeding + streptozotocin (STZ) group ; D was high-lipids and high- sucrose feeding + doxorubicin hydrochloride + STZ group ; E was high-lipids and high-sucrose feeding + mono-nephrectomy + STZ group. The body weight, food-intake, water-intake volume, blood sugar, microprotein in urine were detected in every two weeks. Twelve weeks later after model establishment, the rats were put to death, then heart blood were prepared and kidney was weighed. Results Although laking more food and water, the rats of group E were more emaciated, of higher blood sugar and microprotein in urine, and increased kidney/body weight ratio. There was significant difference between the rats in group E and groups A, B, C, D. Conclusion The rat model established by first high-lipids and high-sucrose feeding for 4 weeks, then mono-nephrectomy, and 2 weeks later intraperitoneal administration of STZ is ideal.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第22期2247-2249,共3页 Journal of Third Military Medical University
关键词 糖尿病肾病 动物/模型 单肾切除 链脲佐菌素 阿霉素 diabetic nephropathy animal/model mono-nephrectomy streptozotocin doxorubicin hydrochloride
  • 相关文献

参考文献7

  • 1VORA J,CARIDES G,ROBINSON P.Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus:a retrospective cost-effectiveness analysis in the United Kingdom[J].Curr Ther Res,2005,66(6):475 -485.
  • 2DALLA-VESTRA M,FIORETTO P.Diabetic nephropathy:renal structural studies in type 1 and 2 diabetic patients[J].Inter Con Ser,2003,125 (3):163-169.
  • 3郭啸华,刘志红,李恒,黎磊石.高糖高脂饮食诱导的2型糖尿病大鼠模型及其肾病特点[J].中国糖尿病杂志,2002,10(5):290-294. 被引量:304
  • 4SAINI K S,THOMPSON C,WINTERFORD C M,et al.Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line,INS-1[J].Biochem Mol Biol Int,1996,39(6):1229-1236.
  • 5张悦,魏民,王谦,楚非,严京,李伯光,贾旭.阿霉素复制大鼠微小病变肾病模型的研究[J].北京中医药大学学报,2002,25(2):16-18. 被引量:35
  • 6YOKOZAWA T,NAKAGAWA T,WAKAKI K,et al.Animal model of diabetic nephropathy[J].Exp Toxicol Pathol,2001,53 (5):359-363.
  • 7OLIVETTI G,ANVERSA P,RIGAMONTI W,et al.Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy.A light microscope study[J].J Cell Biol,1977,75(2 Pt1):573 -585.

二级参考文献12

  • 1陈重义,刘利平.蛋白尿大鼠肾小球基底膜阴离子位点变化[J].中华病理学杂志,1993,22(6):350-352. 被引量:3
  • 2Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews, 1985,6 : 45-86.
  • 3Bryer-Ash M, Foilett L, Hodges N, et al. Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor activity in the rat in vivo. Metabolism, 1995,44:705-711.
  • 4Proietto J, Filippis A, Nakhla C, et al. Nutrient-induced insulin resistance. Mol Cell Endocrinol, 1999,151:143-149.
  • 5Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia,1996,39:1569-1576.
  • 6Joles JA, Kunter U, Janssen U, et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.J Am Soc Nephrol, 2000,11 : 669-683.
  • 7Dominguez JH, Tang N, Xu W, et al. Studies of renal injury Ⅲ: lipid-induced nephropathy in type Ⅱ diabetes. Kidney Int,2000,57 : 92-104.
  • 8Ravid M, Brosh D, Ravid-Safran D, et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Inter Mecl, 1998,158:998-1004.
  • 9Daniels MC, McClain DA, Crook ED. Transcriptional regulation of transforming growth factor beta by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci, 2000,319:138-142.
  • 10Michel O, Heudes D, Lamarre I, et al. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney Int, 1997,52:1532-1542.

共引文献337

同被引文献262

引证文献29

二级引证文献282

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部